BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36713548)

  • 1. Prognostic value of Siglec-15 expression in patients with solid tumors: A meta-analysis.
    Jiang KY; Qi LL; Liu XB; Wang Y; Wang L
    Front Oncol; 2022; 12():1073932. PubMed ID: 36713548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of Long Noncoding RNA CRNDE as a Novel Biomarker in Solid Cancers: An Updated Systematic Review and Meta-Analysis.
    Zhou Y; Wang R; Xu T; Xie P; Zhang Y; Zhang A; Wang X; Yang C; Yang H; Zhu S
    J Cancer; 2019; 10(11):2386-2396. PubMed ID: 31258743
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognostic value of B7-H3 expression in patients with solid tumors: a meta-analysis.
    Zhang X; Fang C; Zhang G; Jiang F; Wang L; Hou J
    Oncotarget; 2017 Nov; 8(54):93156-93167. PubMed ID: 29190985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated PD-L1 expression predicts poor survival outcomes in patients with cervical cancer.
    Gu X; Dong M; Liu Z; Mi Y; Yang J; Zhang Z; Liu K; Jiang L; Zhang Y; Dong S; Shi Y
    Cancer Cell Int; 2019; 19():146. PubMed ID: 31143091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prognostic Value of Decreased LKB1 in Solid Tumors: A Meta-Analysis.
    Xiao J; Zou Y; Chen X; Gao Y; Xie M; Lu X; Li W; He B; He S; You S; Chen Q
    PLoS One; 2016; 11(4):e0152674. PubMed ID: 27035914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of HHLA2 expression in solid tumors: A meta-analysis based on the Chinese population.
    Zhang C; Xu J; Ye J; Zhang X
    Medicine (Baltimore); 2021 Jul; 100(30):e26789. PubMed ID: 34397730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors.
    Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y
    Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of octamer binding transcription factor 4 for patients with solid tumors: A meta-analysis.
    Zhao X; Lu H; Sun Y; Liu L; Wang H
    Medicine (Baltimore); 2020 Oct; 99(42):e22804. PubMed ID: 33080755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between Alpha B-crystallin expression and prognosis in patients with solid tumors: A protocol for systematic review and meta-analysis.
    Yang M; Li Y; Tian F
    Medicine (Baltimore); 2021 Feb; 100(7):e24831. PubMed ID: 33607849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of high IMP3 expression in solid tumors: a meta-analysis.
    Chen L; Xie Y; Li X; Gu L; Gao Y; Tang L; Chen J; Zhang X
    Onco Targets Ther; 2017; 10():2849-2863. PubMed ID: 28652767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of PD-L1 in solid tumor: An updated meta-analysis.
    Wang Q; Liu F; Liu L
    Medicine (Baltimore); 2017 May; 96(18):e6369. PubMed ID: 28471952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of Kindlin-2 expression in patients with solid tumors: a meta-analysis.
    Liu S; Chen S; Ma K; Shao Z
    Cancer Cell Int; 2018; 18():166. PubMed ID: 30386175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
    Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
    PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation Between PD-L2 Expression and Clinical Outcome in Solid Cancer Patients: A Meta-Analysis.
    Yang H; Zhou X; Sun L; Mao Y
    Front Oncol; 2019; 9():47. PubMed ID: 30891423
    [No Abstract]   [Full Text] [Related]  

  • 15. Pre-treatment Glasgow prognostic score and modified Glasgow prognostic score may be potential prognostic biomarkers in urological cancers: a systematic review and meta-analysis.
    Qi F; Xu Y; Zheng Y; Li X; Gao Y
    Ann Transl Med; 2019 Oct; 7(20):531. PubMed ID: 31807513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of programmed cell death-ligand 1 expression on circulating tumor cells in various cancers: A systematic review and meta-analysis.
    Ouyang Y; Liu W; Zhang N; Yang X; Li J; Long S
    Cancer Med; 2021 Oct; 10(20):7021-7039. PubMed ID: 34423578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive Values of Programmed Cell Death-Ligand 1 Expression for Prognosis, Clinicopathological Factors, and Response to Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Inhibitors in Patients With Gynecological Cancers: A Meta-Analysis.
    Zhang C; Yang Q
    Front Oncol; 2020; 10():572203. PubMed ID: 33634012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of the prognostic value of C-C chemokine receptor type 7 in patients with solid tumors.
    Zu G; Luo B; Yang Y; Tan Y; Tang T; Zhang Y; Chen X; Sun D
    Cancer Manag Res; 2019; 11():1881-1892. PubMed ID: 30881115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic role of indoleamine 2,3-dioxygenase 1 expression in solid tumors: A systematic review and meta-analysis.
    Zhang H; Li J; Zhou Q
    Front Oncol; 2022; 12():954495. PubMed ID: 36212460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic role of galectin-3 expression in patients with solid tumors: a meta-analysis of 36 eligible studies.
    Wang Y; Liu S; Tian Y; Wang Y; Zhang Q; Zhou X; Meng X; Song N
    Cancer Cell Int; 2018; 18():172. PubMed ID: 30410421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.